OncoQuest reports promising interim data from phase IIb study of oregovomab in ovarian cancer Nov. 30, 2016
Xencor initiates phase I study of XmAb-13676 for CD20-expressing hematologic malignancies Nov. 24, 2016
Viral Gene announces phase II funding for novel vaccine to prevent colon cancer metastases Nov. 24, 2016
FDA approves Darzalex in combination with standard of care for relapsed multiple myeloma Nov. 22, 2016
RSS